We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,867,609 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.82 | 68.12B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 7281N
GlaxoSmithKline PLC
10 May 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------ -------------------------------------------------------- Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan ------------------------------------------------------------ -------------------------------------------------------- Period of return: From: 1 November 2017 To: 30 April 2018 ---------------------------------- ------------------------ ------------------------- ------ --------------------- Balance of unallotted securities under scheme(s) from previous return: 199,082 ------------------------------------------------------------ -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------------------ -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 165,219 ------------------------------------------------------------ -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 33,863 ------------------------------------------------------------ -------------------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------ -------------------------------------------------------- Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares ------------------------------------------------------------ -------------------------------------------------------- Period of return: From: 1 November 2017 To: 30 April 2018 ---------------------------------- ------------------------ ------------------------- ------ --------------------- Balance of unallotted securities under scheme(s) from previous return: 3,559,772 ------------------------------------------------------------ -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------------------ -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 865,821 ------------------------------------------------------------ -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 2,693,951 ------------------------------------------------------------ -------------------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------------------ -------------------------------------------- Name of scheme: GlaxoSmithKline Share Option Plan - ADS ------------------------------------------------------------------------ -------------------------------------------- Period of return: From: 1 November 2017 To: 30 April 2018 ---------------------------------------------- ------------------------ ------------------- ----- ---------------- Balance of unallotted securities under scheme(s) from previous return: 8,185,120 ------------------------------------------------------------------------ -------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------------------------------ -------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 275,126 ------------------------------------------------------------------------ -------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 7,909,994 ------------------------------------------------------------------------ -------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: GlaxoSmithKline plc ----------------------------------------------------------------------- --------------------------------------------- Name of scheme: GlaxoSmithKline plc Share Save Plan 2012 ----------------------------------------------------------------------- --------------------------------------------- Period of return: From: 1 November 2017 To: 30 April 2018 --------------------------------------------- ------------------------ -------------------- ----- ---------------- Balance of unallotted securities under scheme(s) from previous return: 1,542,070 ----------------------------------------------------------------------- --------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ----------------------------------------------------------------------- --------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 714,764 ----------------------------------------------------------------------- --------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 827,306 ----------------------------------------------------------------------- --------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in Block Listing Six Monthly Returns:
1. Glaxo Wellcome UK Share Option Scheme 2. Glaxo Wellcome International Share Option Scheme 3. Glaxo Wellcome 1999 Share Option Plan 4. SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares 5. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS 6. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRMMGMKVGVGRZM
(END) Dow Jones Newswires
May 10, 2018 12:20 ET (16:20 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
